CClinicalTrials.gg
Enrolling by invitationNCT06978335Updated May 28, 2025

Acupoint Stimulation Improves Postoperative Wound Pain

An interventional study of Acupoint Stimulation and Sham Acupoint Stimulation in Abdominal Surgeries, Pain and Acupuncture Points, sponsored by Cheng-Hsin General Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-28.

Sponsored by Cheng-Hsin General Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year ago, but the record still lists the study as enrolling by invitation.
  • Registered 10 months after the study started (first participant enrolled Jun 2024, registered May 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Postoperative pain remains one of the most common and distressing symptoms experienced by surgical patients. Poorly managed postoperative pain can impede recovery, reduce patient willingness to mobilize, increase the risk of complications, and negatively affect overall quality of life. Currently, opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) are the primary pharmacological strategies for managing postoperative pain. However, these medications often carry the risk of adverse effects and may not adequately address all aspects of patient comfort and recovery.

In response to this challenge, this study aims to evaluate the effects of a non-pharmacological, non-invasive intervention-acupoint stimulation-on postoperative wound pain and mobilization in patients undergoing abdominal surgery. Ultimately, this study seeks to contribute to the development of more diversified and patient-centered pain management strategies, with the expectation that the integration of Chinese and Western medicine will lead to improved patient care and enhanced postoperative recovery.

02

Conditions studied

  • Abdominal Surgeries
  • Pain
  • Acupuncture Points

Keywords

  • acupoint stimulation
  • postoperative pain
03

In context

Lead sponsor

Cheng-Hsin General Hospital is the lead sponsor of 22 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥ 18 years
  • Surgical wound length ≥ 10 cm
  • American Society of Anesthesiologists (ASA) physical status classification I to III
  • Receiving intravenous patient-controlled analgesia (IV PCA)
  • Clear consciousness and ability to communicate
  • Willingness to participate and provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Presence of arrhythmia
  • Implanted artificial cardiac pacemaker
  • Cutaneous lesions at the acupoint or auricular application sites
  • History of chronic pain or abdominal surgery within the past 6 months
  • Non-ambulatory status prior to surgery
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Experimental: Acupoint Stimulation

    Acupoint stimulation was administered on six points and auricular points on three points on the left ear, additional auricular points were selected according to the abdominal organ involved in surgery and its corresponding meridian representation on the auricle.

    Other: Acupoint Stimulation

  • Sham comparator
    Control: Sham Acupoint Stimulation

    Other: Sham Acupoint Stimulation

Interventions

  • OtherAcupoint Stimulation

    This intervention involves acupoint stimulation and auricular acupressure. Stimulation of selected body acupoints is administered by trained personnel following a standardized protocol. The intervention is provided once daily for three consecutive days, beginning post-surgery. For auricular acupressure, additional auricular points are chosen based on the involved abdominal organ and its corresponding viscera-meridian locations on the auricle. Vaccaria seeds are applied to the selected points with adhesive patches, and patients are instructed to apply pressure to the points regularly throughout the day.

  • OtherSham Acupoint Stimulation

    Participants in this group will receive a sham acupoint stimulation procedure. Acupoint stimulation will be using identical procedures to the experimental group, without applying pressure. No stimulation or manipulation was performed. The frequency and timing of the sham intervention matched that of the experimental group.

06

What researchers measure

Primary outcomes

  1. Pain Intensity Measured by Visual Analog Scale (VAS)

    Pain intensity will be assessed using the Visual Analog Scale (VAS). The primary analysis will focus on changes in pain intensity over time between the two groups.

    Time frame: At 1, 4, 12, 24, 48, and 72 hours post-surgery

Secondary outcomes

  1. Pain Impact Assessed by Brief Pain Inventory - Taiwan Version (BPI-Taiwan)

    The Brief Pain Inventory - Taiwan version (BPI-Taiwan) will be used to assess the impact of pain on various aspects of daily functioning. Total and subscale scores will be analyzed to evaluate differences in pain interference between the two groups.

    Time frame: On postoperative Day 3

Other outcomes

  1. Total Analgesic Consumption Within 72 Hours After Surgery

    This outcome evaluates whether acupoint stimulation reduces the need for postoperative analgesics.

    Time frame: Within 72 hours after surgery

  2. Time to First Ambulation After Surgery

    Time from completion of surgery to the first successful ambulation will be recorded. Recorded as an indicator of overall postoperative mobility and functional recovery.

    Time frame: Within 72 hours after surgery

07

Study locations

1 site
  • Cheng Hsin General Hospital
    Taipei, Peitou Dist 112, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06978335
Lead sponsor
Cheng-Hsin General Hospital
Responsible party
Sponsor
First posted
May 18, 2025
Start date
Jun 19, 2024
Primary completion
Sep 30, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
May 28, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion